Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

EXELIXIS, INC. (EXEL) Stock Forecast 2025 - AI Price Prediction & Analysis

EXELIXIS, INC. (EXEL) AI Stock Price Forecast & Investment Analysis

EXELIXIS, INC. (EXEL) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

EXELIXIS, INC. (Stock Symbol: EXEL) is a leading company in the Life Sciences sector , specifically operating within the Biological Products, (No Diagnostic Substances) industry. The organization employs approximately 1493 professionals worldwide . The company has established itself as a major market leader with significant institutional backing.

Financial Performance & Key Metrics Analysis

Annual Revenue: $2230 million generating a 205.8% net profit margin .

Market Capitalization: $11059 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 14.2% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for EXELIXIS, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

EXELIXIS, INC. strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence . The company demonstrates robust operational efficiency through strong free cash flow generation of $453 million annually , complemented by impressive -60.3% year-over-year cash flow growth. The company maintains a healthy 852.5% gross margin, indicating strong pricing power and operational efficiency.

EXELIXIS, INC. Stock Price Chart and Technical Analysis

Loading EXELIXIS, INC. interactive price chart and technical analysis...

Comprehensive Investment Metrics & Financial Analysis - EXELIXIS, INC. (EXEL)

Deep dive into EXELIXIS, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if EXELIXIS, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For EXELIXIS, INC.: With a P/E ratio of 18.36, the market moderately values the company's earnings.

P/E Ratio 18.36x
P/B Ratio 5.44x
Market Cap $11059M
EPS $2.16
Book Value/Share $7.10
Revenue/Share $7.79
FCF/Share $0.98
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently EXELIXIS, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For EXELIXIS, INC.: An ROE of 14.2% shows good shareholder value creation.

ROE 14.2%
ROA 12.3%
ROIC 13.6%
Gross Margin 852.5%
Net Margin 205.8%
EBT Margin 25.1%
Tax Rate 21.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess EXELIXIS, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For EXELIXIS, INC.: A current ratio of 6.37 indicates strong liquidity.

Current Ratio 6.37x
Quick Ratio 6.09x
D/E Ratio 0.02x
Financial Leverage 1.16x
Interest Coverage 19.3x
Working Capital $1241M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal EXELIXIS, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For EXELIXIS, INC.: Free cash flow of $453M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $509M
Free Cash Flow $453M
Capital Spending $-56M
OCF Growth YoY -60.3%
FCF Growth YoY -65.3%
FCF/Sales 29.8%
CapEx/Sales 3.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively EXELIXIS, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For EXELIXIS, INC.: An asset turnover of 0.63x suggests room for improvement in asset utilization.

Asset Turnover 0.63x
Receivables Turnover 8.3x
Inventory Turnover 2.0x
Fixed Assets Turnover 16.5x
Days Sales Outstanding 44 days
Days Inventory 184 days
Payables Period 107 days
Cash Conversion Cycle 121 days
Understanding Financial Statement Data

What these metrics mean: Key figures from EXELIXIS, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For EXELIXIS, INC.: With annual revenue of $2230M, EXELIXIS, INC. operates at significant scale.

Income Statement ($ Millions)
Total Revenue $2230M
Net Income $233M
R&D Expense $906M
SG&A Expense $26M
Cost of Goods Sold $78M
Balance Sheet Highlights ($ Millions)
Total Current Assets $69M
Cash & Short-term Investments $59M
Total Liabilities $14M
Short-term Debt $32M
Accounts Receivable $7M
Inventory $1M
Dividend & Shareholder Information
Shares Outstanding 286M
Growth Metrics (YoY)
EPS Growth 4.7%

EXELIXIS, INC. (EXEL) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for EXELIXIS, INC. stock analysis.

Loading EXELIXIS, INC. comprehensive fundamental analysis and insider trading data...

Latest EXELIXIS, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting EXELIXIS, INC. (EXEL) stock price and investment outlook.

📰 We are currently updating our news feed for EXELIXIS, INC.. Check back soon for the latest market analysis and company updates.

EXELIXIS, INC. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of EXELIXIS, INC. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABOS Unlock Forecast $93M -1.9x 0.8x
ABP Unlock Forecast $0M x 0.0x
ABPWW Unlock Forecast $0M x 0.0x
ACLX Unlock Forecast $3725M -74.1x 8.9x
ACOG Unlock Forecast $130M x 4.1x
ADAP Unlock Forecast $91M -13.2x -11.8x
ADMA Unlock Forecast $4374M 20.9x 11.0x
ADPT Unlock Forecast $1977M -4.6x 11.0x
ADVM Unlock Forecast $58M -1.8x 2.2x
AGEN Unlock Forecast $136M -0.5x -0.5x
AIM Unlock Forecast $2M -0.5x -183.3x
AIMI Unlock Forecast $2M x x
ALEC Unlock Forecast $255M -1.2x 3.6x
ALGS Unlock Forecast $96M -19.2x 0.9x
ALLO Unlock Forecast $262M -1.4x 0.8x
ALVR Unlock Forecast $49M -0.5x 0.4x
AMGN Unlock Forecast $158903M 24.0x 21.4x
APGE Unlock Forecast $2241M -20.5x 4.3x
APTO Unlock Forecast $6M 0.0x -1.3x
APTOF Unlock Forecast $3M x x
ARMP Unlock Forecast $97M -1.0x -1.6x
ARTV Unlock Forecast $70M x 0.5x
ATHA Unlock Forecast $16M -0.2x 0.5x
ATRA Unlock Forecast $143M 24.7x -1.1x
ATYR Unlock Forecast $515M -3.6x 6.9x
AURA Unlock Forecast $407M -4.9x 2.3x
AUTL Unlock Forecast $466M x 1.3x
AVXL Unlock Forecast $814M -17.3x 9.0x
BCAB Unlock Forecast $125M -1.1x 1.0x
BCDA Unlock Forecast $12M -0.6x -7.8x
BCLI Unlock Forecast $7M -4.9x -0.9x
BCRX Unlock Forecast $1802M -12.1x -4.0x
BDTX Unlock Forecast $168M 11.6x 1.3x
BEAM Unlock Forecast $1677M -12.6x 1.6x
BIIB Unlock Forecast $18125M 12.8x 1.5x
BKHA Unlock Forecast $0M x 0.0x
BKHAU Unlock Forecast $0M x 0.0x
BLUE Unlock Forecast $49M -0.2x -0.8x
CABA Unlock Forecast $148M -1.6x 0.8x
CADL Unlock Forecast $338M -4.6x 4.5x
CCCC Unlock Forecast $185M -2.6x 1.1x
CDTX Unlock Forecast $728M -1.0x 5.1x
CELZ Unlock Forecast $8M -3.4x 1.2x
CERO Unlock Forecast $3M x -196.2x
CEROW Unlock Forecast $2M x -0.5x
CGEM Unlock Forecast $449M -4.1x 0.8x
CGEN Unlock Forecast $136M x 2.7x
CGON Unlock Forecast $2052M x 3.1x
CGTX Unlock Forecast $183M -0.5x 26.0x
CHRO Unlock Forecast $8M x -2.0x
CHRS Unlock Forecast $143M 0.8x 1.2x
CLDI Unlock Forecast $6M -0.9x 3.3x
CMPX Unlock Forecast $418M -4.8x 4.5x
COEPW Unlock Forecast $M x x
CRBU Unlock Forecast $172M -1.5x 1.0x
CRDF Unlock Forecast $154M -4.0x 2.6x
CRGX Unlock Forecast $215M x 0.9x
CRIS Unlock Forecast $18M -0.3x -2.9x
CRSP Unlock Forecast $4801M -12.1x 2.8x
CSBR Unlock Forecast $111M -17.8x 20.4x
CVM Unlock Forecast $51M -0.9x 7.2x
CYTH Unlock Forecast $26M -0.6x -1.9x
CYTHW Unlock Forecast $7M x -0.5x
DBVT Unlock Forecast $1479M -3.3x 514.8x
DNA Unlock Forecast $568M -13.9x 0.3x
DNLI Unlock Forecast $2111M -8.7x 1.9x
DTIL Unlock Forecast $58M -2.2x 1.7x
DYAI Unlock Forecast $28M -7.3x 11.4x
EDIT Unlock Forecast $231M -0.8x 3.7x
ELEV Unlock Forecast $22M -1.0x 0.5x
ELUT Unlock Forecast $94M -1.4x -0.1x
ENGN Unlock Forecast $221M 3.7x 1.0x
ENGNW Unlock Forecast $37M x 0.1x
ENTX Unlock Forecast $91M 8.5x 5.3x
ENZ Unlock Forecast $25M -3.0x 0.5x
ENZB Unlock Forecast $37M x 0.8x
ESLA Unlock Forecast $36M -3.1x -16.9x
ESLAW Unlock Forecast $4M x 5.3x
EXEL Unlock Forecast $11059M 18.4x 5.4x
EXOZ Unlock Forecast $78M x 10.8x
FATE Unlock Forecast $136M -1.3x 0.5x
FDMT Unlock Forecast $396M -3.0x 0.9x
FENC Unlock Forecast $232M 1758.3x -39.7x
FNCH Unlock Forecast $20M -0.1x 1.4x
FTII Unlock Forecast $-26M x -0.7x
FTIIU Unlock Forecast $-26M x -0.8x
FTIIW Unlock Forecast $0M x 0.0x
GILD Unlock Forecast $144266M 22.9x 7.3x
GLUE Unlock Forecast $400M 16.5x 1.5x
GNTA Unlock Forecast $64M x 5.1x
GPLB Unlock Forecast $M x x
HALO Unlock Forecast $9010M 16.2x 27.1x
HLVX Unlock Forecast $103M -0.6x 0.7x
HUMA Unlock Forecast $247M -3.3x 61.0x
HUMAW Unlock Forecast $163M x -2.6x
IBRX Unlock Forecast $2427M -3.6x -4.1x
IKNA Unlock Forecast $61M -1.3x 0.5x
IKT Unlock Forecast $170M -1.0x 2.1x
IMCR Unlock Forecast $1659M x 4.3x
IMVT Unlock Forecast $2607M -14.5x 4.3x
INAB Unlock Forecast $21M -0.4x 2.4x
INBX Unlock Forecast $387M -6.8x 5.6x
INKT Unlock Forecast $59M -1.5x -1.4x
INMB Unlock Forecast $64M -2.5x 2.2x
INTS Unlock Forecast $8M -2.2x 3.6x
IOVA Unlock Forecast $920M -4.5x 1.3x
IPSC Unlock Forecast $47M -0.7x 0.2x
ITOS Unlock Forecast $393M -2.8x 0.7x
IVVD Unlock Forecast $62M -0.4x 1.5x
IZTC Unlock Forecast $99M x -27.5x
JSPR Unlock Forecast $48M -3.2x 2.0x
JSPRW Unlock Forecast $3M x 0.0x
KLRS Unlock Forecast $47M x 0.9x
KLTO Unlock Forecast $39M x 3.7x
KLTOW Unlock Forecast $1M x 0.4x
KOD Unlock Forecast $539M -2.5x 7.7x
KRBPQ Unlock Forecast $0M x x
KRYS Unlock Forecast $4487M 30.6x 4.3x
KYMR Unlock Forecast $3541M -17.8x 3.7x
KYTX Unlock Forecast $166M x 0.9x
LADX Unlock Forecast $M x x
LCTX Unlock Forecast $267M -4.7x 5.5x
LENZ Unlock Forecast $1140M -6.7x 5.5x
LIMN Unlock Forecast $0M x x
LXEO Unlock Forecast $265M -0.4x 1.9x
MAZE Unlock Forecast $592M x 2.3x
MGTX Unlock Forecast $693M -3.4x 20.9x
MGX Unlock Forecast $72M x 0.4x
MRNA Unlock Forecast $10550M -3.2x 1.1x
NBIX Unlock Forecast $13787M 39.6x 5.1x
NKGN Unlock Forecast $4M -0.1x -0.2x
NKGNW Unlock Forecast $1M x 0.0x
NMRA Unlock Forecast $262M -3.9x 1.4x
NVAX Unlock Forecast $1391M 3.3x 37.0x
OCGN Unlock Forecast $298M -4.3x 18.7x
OMGA Unlock Forecast $9M -0.7x 0.8x
OMGAQ Unlock Forecast $0M x 0.0x
ONVO Unlock Forecast $35M -0.4x 95.9x
OTLK Unlock Forecast $73M -0.2x -2.3x
PALI Unlock Forecast $4M -0.2x 0.7x
PASG Unlock Forecast $24M -0.6x 0.6x
PCVX Unlock Forecast $4387M -20.4x 1.4x
PHGE Unlock Forecast $15M 1.5x 0.8x
PLUR Unlock Forecast $-5M -1.4x -9.1x
PLX Unlock Forecast $129M 20.5x 2.6x
PMCB Unlock Forecast $7M -2.6x 0.2x
PRME Unlock Forecast $477M -1.5x 7.8x
PROK Unlock Forecast $-68M x 0.0x
PSTX Unlock Forecast $926M -9.6x 10.6x
PTHS Unlock Forecast $M x x
QGEN Unlock Forecast $11177M x 3.1x
QNCX Unlock Forecast $87M -1.7x 7.5x
REPL Unlock Forecast $932M -3.8x 2.2x
RGEN Unlock Forecast $6531M 8219.1x 3.3x
RGNX Unlock Forecast $463M -1.8x 2.2x
RLAY Unlock Forecast $634M -2.0x 1.0x
RVMD Unlock Forecast $7134M -11.1x 3.4x
RVMDW Unlock Forecast $16M x 0.0x
RXRX Unlock Forecast $2138M -4.7x 2.3x
SABS Unlock Forecast $24M -2.3x 1.1x
SABSW Unlock Forecast $0M x 0.0x
SANA Unlock Forecast $852M -2.1x 7.0x
SCLX Unlock Forecast $62M -0.4x -0.3x
SCLXW Unlock Forecast $25M x -0.1x
SCNI Unlock Forecast $5359M -287.8x -2577.2x
SGMO Unlock Forecast $141M -1.6x 7.2x
SLDB Unlock Forecast $495M -0.9x 1.7x
SLXN Unlock Forecast $4M x 34.7x
SLXNW Unlock Forecast $866M x -189.1x
SNTI Unlock Forecast $51M -1.1x 1.3x
SRRK Unlock Forecast $4069M -18.5x 13.0x
SRZN Unlock Forecast $98M -0.5x 2.1x
SRZNW Unlock Forecast $0M x 0.0x
STRO Unlock Forecast $73M -1.0x -2.5x
SWTX Unlock Forecast $3539M -9.9x 8.5x
TARA Unlock Forecast $129M -2.1x 0.9x
TARS Unlock Forecast $2417M -12.4x 7.3x
TCBP Unlock Forecast $37M x 34.5x
TCBPW Unlock Forecast $1M x 1.0x
TCBPY Unlock Forecast $21M x 19.1x
TCRX Unlock Forecast $243M -4.6x 1.4x
TECH Unlock Forecast $8155M 75.2x 4.0x
TECX Unlock Forecast $490M -8.9x 1.7x
TIL Unlock Forecast $182M -1.1x 1.3x
TNYA Unlock Forecast $154M -2.5x 1.5x
TRML Unlock Forecast $600M -3.5x 2.3x
TSBX Unlock Forecast $8M -0.1x 0.6x
TSHA Unlock Forecast $851M -3.0x 3.4x
TTNP Unlock Forecast $8M -0.5x 4.5x
TVGN Unlock Forecast $181M x -29.3x
TVGNW Unlock Forecast $11M x -1.9x
TWST Unlock Forecast $1720M -12.6x 3.6x
VACH Unlock Forecast $-1436M x 0.0x
VACHU Unlock Forecast $-1585M x 0.0x
VCEL Unlock Forecast $1868M 262.8x 6.1x
VIGL Unlock Forecast $384M -1.1x 9.3x
VIR Unlock Forecast $636M -2.0x 0.7x
VIVS Unlock Forecast $3M x 0.3x
VOR Unlock Forecast $273M -0.6x 3.9x
VXRT Unlock Forecast $80M -0.9x 2.4x
VYGR Unlock Forecast $201M 570.6x 0.8x
WINT Unlock Forecast $18M -0.4x 4.2x
XFOR Unlock Forecast $8M 6.4x 0.4x
ZIVO Unlock Forecast $70M -31.3x -2.0x
ZURA Unlock Forecast $131M 5.0x 0.9x

Frequently Asked Questions - EXELIXIS, INC. Stock Forecast

How accurate are EXELIXIS, INC. stock predictions?

Our AI model demonstrates 57% historical accuracy for EXEL predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence EXELIXIS, INC. stock price forecasts?

Our analysis considers EXELIXIS, INC.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is EXELIXIS, INC. a good investment in 2025?

Based on our AI analysis, EXELIXIS, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are EXELIXIS, INC. forecasts updated?

EXELIXIS, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced EXELIXIS, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for EXELIXIS, INC. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...